+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

ePRO, E-Patient Diaries and eCOA - Global Market Trajectory & Analytics

  • ID: 5139503
  • Report
  • April 2021
  • Region: Global
  • Global Industry Analysts, Inc

FEATURED COMPANIES

  • ArisGlobal LLC
  • Bracket Global LLC
  • CRF Health
  • ERT Clinical
  • HealthDiary Inc.
  • ICON PLC
  • MORE
Global ePRO, E-Patient Diaries and eCOA Market to Reach $3.2 Billion by 2027

Amid the COVID-19 crisis, the global market for ePRO, E-Patient Diaries and eCOA estimated at US$1.2 Billion in the year 2020, is projected to reach a revised size of US$3.2 Billion by 2027, growing at a CAGR of 14.7% over the period 2020-2027. eCOA, one of the segments analyzed in the report, is projected to record 14.1% CAGR and reach US$2 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the E-Patient Diaries segment is readjusted to a revised 15.7% CAGR for the next 7-year period.



The U.S. Market is Estimated at $366.9 Million, While China is Forecast to Grow at 14.2% CAGR

The ePRO, E-Patient Diaries and eCOA market in the U.S. is estimated at US$366.9 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$566.3 Million by the year 2027 trailing a CAGR of 14.2% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 13.1% and 12.6% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 10.8% CAGR.

Select Competitors (Total 46 Featured):
  • ArisGlobal LLC
  • Bracket Global LLC
  • CRF Health
  • ERT Clinical
  • HealthDiary Inc.
  • ICON PLC
  • Kayentis SAS
  • Medidata Solutions, Inc.
  • OmniComm Systems, Inc.
  • Parexel International Corporation
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • ArisGlobal LLC
  • Bracket Global LLC
  • CRF Health
  • ERT Clinical
  • HealthDiary Inc.
  • ICON PLC
  • MORE
I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Impact of Covid-19 and a Looming Global Recession
2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE
  • Table 1: World Current & Future Analysis for ePRO, E-Patient Diaries and eCOA by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2018 through 2027 and % CAGR
  • Table 2: World Historic Review for ePRO, E-Patient Diaries and eCOA by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 and % CAGR
  • Table 3: World 15-Year Perspective for ePRO, E-Patient Diaries and eCOA by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2012, 2018 & 2027
  • Table 4: World Current & Future Analysis for eCOA by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2018 through 2027 and % CAGR
  • Table 5: World Historic Review for eCOA by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 and % CAGR
  • Table 6: World 15-Year Perspective for eCOA by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2018 & 2027
  • Table 7: World Current & Future Analysis for E-Patient Diaries by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2018 through 2027 and % CAGR
  • Table 8: World Historic Review for E-Patient Diaries by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 and % CAGR
  • Table 9: World 15-Year Perspective for E-Patient Diaries by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2018 & 2027
  • Table 10: World Current & Future Analysis for Clinical Trial Sponsors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2018 through 2027 and % CAGR
  • Table 11: World Historic Review for Clinical Trial Sponsors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 and % CAGR
  • Table 12: World 15-Year Perspective for Clinical Trial Sponsors by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2018 & 2027
  • Table 13: World Current & Future Analysis for Contract Research Organizations (CROs) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2018 through 2027 and % CAGR
  • Table 14: World Historic Review for Contract Research Organizations (CROs) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 and % CAGR
  • Table 15: World 15-Year Perspective for Contract Research Organizations (CROs) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2018 & 2027
  • Table 16: World Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2018 through 2027 and % CAGR
  • Table 17: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 and % CAGR
  • Table 18: World 15-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2018 & 2027
  • Table 19: World Current & Future Analysis for Academic Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2018 through 2027 and % CAGR
  • Table 20: World Historic Review for Academic Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 and % CAGR
  • Table 21: World 15-Year Perspective for Academic Institutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2018 & 2027
  • Table 22: World Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2018 through 2027 and % CAGR
  • Table 23: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 and % CAGR
  • Table 24: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2018 & 2027
III. MARKET ANALYSIS
  • UNITED STATES
  • Table 25: USA Current & Future Analysis for ePRO, E-Patient Diaries and eCOA by Type of Solution - eCOA and E-Patient Diaries - Independent Analysis of Annual Sales in US$ Thousand for the Years 2018 through 2027 and % CAGR
  • Table 26: USA Historic Review for ePRO, E-Patient Diaries and eCOA by Type of Solution - eCOA and E-Patient Diaries Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 and % CAGR
  • Table 27: USA 15-Year Perspective for ePRO, E-Patient Diaries and eCOA by Type of Solution - Percentage Breakdown of Value Sales for eCOA and E-Patient Diaries for the Years 2012, 2018 & 2027
  • Table 28: USA Current & Future Analysis for ePRO, E-Patient Diaries and eCOA by End-Use - Clinical Trial Sponsors, Contract Research Organizations (CROs), Hospitals, Academic Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2018 through 2027 and % CAGR
  • Table 29: USA Historic Review for ePRO, E-Patient Diaries and eCOA by End-Use - Clinical Trial Sponsors, Contract Research Organizations (CROs), Hospitals, Academic Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 and % CAGR
  • Table 30: USA 15-Year Perspective for ePRO, E-Patient Diaries and eCOA by End-Use - Percentage Breakdown of Value Sales for Clinical Trial Sponsors, Contract Research Organizations (CROs), Hospitals, Academic Institutes and Other End-Uses for the Years 2012, 2018 & 2027
  • CANADA
  • Table 31: Canada Current & Future Analysis for ePRO, E-Patient Diaries and eCOA by Type of Solution - eCOA and E-Patient Diaries - Independent Analysis of Annual Sales in US$ Thousand for the Years 2018 through 2027 and % CAGR
  • Table 32: Canada Historic Review for ePRO, E-Patient Diaries and eCOA by Type of Solution - eCOA and E-Patient Diaries Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 and % CAGR
  • Table 33: Canada 15-Year Perspective for ePRO, E-Patient Diaries and eCOA by Type of Solution - Percentage Breakdown of Value Sales for eCOA and E-Patient Diaries for the Years 2012, 2018 & 2027
  • Table 34: Canada Current & Future Analysis for ePRO, E-Patient Diaries and eCOA by End-Use - Clinical Trial Sponsors, Contract Research Organizations (CROs), Hospitals, Academic Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2018 through 2027 and % CAGR
  • Table 35: Canada Historic Review for ePRO, E-Patient Diaries and eCOA by End-Use - Clinical Trial Sponsors, Contract Research Organizations (CROs), Hospitals, Academic Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 and % CAGR
  • Table 36: Canada 15-Year Perspective for ePRO, E-Patient Diaries and eCOA by End-Use - Percentage Breakdown of Value Sales for Clinical Trial Sponsors, Contract Research Organizations (CROs), Hospitals, Academic Institutes and Other End-Uses for the Years 2012, 2018 & 2027
  • JAPAN
  • Table 37: Japan Current & Future Analysis for ePRO, E-Patient Diaries and eCOA by Type of Solution - eCOA and E-Patient Diaries - Independent Analysis of Annual Sales in US$ Thousand for the Years 2018 through 2027 and % CAGR
  • Table 38: Japan Historic Review for ePRO, E-Patient Diaries and eCOA by Type of Solution - eCOA and E-Patient Diaries Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 and % CAGR
  • Table 39: Japan 15-Year Perspective for ePRO, E-Patient Diaries and eCOA by Type of Solution - Percentage Breakdown of Value Sales for eCOA and E-Patient Diaries for the Years 2012, 2018 & 2027
  • Table 40: Japan Current & Future Analysis for ePRO, E-Patient Diaries and eCOA by End-Use - Clinical Trial Sponsors, Contract Research Organizations (CROs), Hospitals, Academic Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2018 through 2027 and % CAGR
  • Table 41: Japan Historic Review for ePRO, E-Patient Diaries and eCOA by End-Use - Clinical Trial Sponsors, Contract Research Organizations (CROs), Hospitals, Academic Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 and % CAGR
  • Table 42: Japan 15-Year Perspective for ePRO, E-Patient Diaries and eCOA by End-Use - Percentage Breakdown of Value Sales for Clinical Trial Sponsors, Contract Research Organizations (CROs), Hospitals, Academic Institutes and Other End-Uses for the Years 2012, 2018 & 2027
  • CHINA
  • Table 43: China Current & Future Analysis for ePRO, E-Patient Diaries and eCOA by Type of Solution - eCOA and E-Patient Diaries - Independent Analysis of Annual Sales in US$ Thousand for the Years 2018 through 2027 and % CAGR
  • Table 44: China Historic Review for ePRO, E-Patient Diaries and eCOA by Type of Solution - eCOA and E-Patient Diaries Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 and % CAGR
  • Table 45: China 15-Year Perspective for ePRO, E-Patient Diaries and eCOA by Type of Solution - Percentage Breakdown of Value Sales for eCOA and E-Patient Diaries for the Years 2012, 2018 & 2027
  • Table 46: China Current & Future Analysis for ePRO, E-Patient Diaries and eCOA by End-Use - Clinical Trial Sponsors, Contract Research Organizations (CROs), Hospitals, Academic Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2018 through 2027 and % CAGR
  • Table 47: China Historic Review for ePRO, E-Patient Diaries and eCOA by End-Use - Clinical Trial Sponsors, Contract Research Organizations (CROs), Hospitals, Academic Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 and % CAGR
  • Table 48: China 15-Year Perspective for ePRO, E-Patient Diaries and eCOA by End-Use - Percentage Breakdown of Value Sales for Clinical Trial Sponsors, Contract Research Organizations (CROs), Hospitals, Academic Institutes and Other End-Uses for the Years 2012, 2018 & 2027
  • EUROPE
  • Table 49: Europe Current & Future Analysis for ePRO, E-Patient Diaries and eCOA by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2018 through 2027 and % CAGR
  • Table 50: Europe Historic Review for ePRO, E-Patient Diaries and eCOA by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 and % CAGR
  • Table 51: Europe 15-Year Perspective for ePRO, E-Patient Diaries and eCOA by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2012, 2018 & 2027
  • Table 52: Europe Current & Future Analysis for ePRO, E-Patient Diaries and eCOA by Type of Solution - eCOA and E-Patient Diaries - Independent Analysis of Annual Sales in US$ Thousand for the Years 2018 through 2027 and % CAGR
  • Table 53: Europe Historic Review for ePRO, E-Patient Diaries and eCOA by Type of Solution - eCOA and E-Patient Diaries Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 and % CAGR
  • Table 54: Europe 15-Year Perspective for ePRO, E-Patient Diaries and eCOA by Type of Solution - Percentage Breakdown of Value Sales for eCOA and E-Patient Diaries for the Years 2012, 2018 & 2027
  • Table 55: Europe Current & Future Analysis for ePRO, E-Patient Diaries and eCOA by End-Use - Clinical Trial Sponsors, Contract Research Organizations (CROs), Hospitals, Academic Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2018 through 2027 and % CAGR
  • Table 56: Europe Historic Review for ePRO, E-Patient Diaries and eCOA by End-Use - Clinical Trial Sponsors, Contract Research Organizations (CROs), Hospitals, Academic Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 and % CAGR
  • Table 57: Europe 15-Year Perspective for ePRO, E-Patient Diaries and eCOA by End-Use - Percentage Breakdown of Value Sales for Clinical Trial Sponsors, Contract Research Organizations (CROs), Hospitals, Academic Institutes and Other End-Uses for the Years 2012, 2018 & 2027
  • FRANCE
  • Table 58: France Current & Future Analysis for ePRO, E-Patient Diaries and eCOA by Type of Solution - eCOA and E-Patient Diaries - Independent Analysis of Annual Sales in US$ Thousand for the Years 2018 through 2027 and % CAGR
  • Table 59: France Historic Review for ePRO, E-Patient Diaries and eCOA by Type of Solution - eCOA and E-Patient Diaries Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 and % CAGR
  • Table 60: France 15-Year Perspective for ePRO, E-Patient Diaries and eCOA by Type of Solution - Percentage Breakdown of Value Sales for eCOA and E-Patient Diaries for the Years 2012, 2018 & 2027
  • Table 61: France Current & Future Analysis for ePRO, E-Patient Diaries and eCOA by End-Use - Clinical Trial Sponsors, Contract Research Organizations (CROs), Hospitals, Academic Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2018 through 2027 and % CAGR
  • Table 62: France Historic Review for ePRO, E-Patient Diaries and eCOA by End-Use - Clinical Trial Sponsors, Contract Research Organizations (CROs), Hospitals, Academic Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 and % CAGR
  • Table 63: France 15-Year Perspective for ePRO, E-Patient Diaries and eCOA by End-Use - Percentage Breakdown of Value Sales for Clinical Trial Sponsors, Contract Research Organizations (CROs), Hospitals, Academic Institutes and Other End-Uses for the Years 2012, 2018 & 2027
  • GERMANY
  • Table 64: Germany Current & Future Analysis for ePRO, E-Patient Diaries and eCOA by Type of Solution - eCOA and E-Patient Diaries - Independent Analysis of Annual Sales in US$ Thousand for the Years 2018 through 2027 and % CAGR
  • Table 65: Germany Historic Review for ePRO, E-Patient Diaries and eCOA by Type of Solution - eCOA and E-Patient Diaries Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 and % CAGR
  • Table 66: Germany 15-Year Perspective for ePRO, E-Patient Diaries and eCOA by Type of Solution - Percentage Breakdown of Value Sales for eCOA and E-Patient Diaries for the Years 2012, 2018 & 2027
  • Table 67: Germany Current & Future Analysis for ePRO, E-Patient Diaries and eCOA by End-Use - Clinical Trial Sponsors, Contract Research Organizations (CROs), Hospitals, Academic Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2018 through 2027 and % CAGR
  • Table 68: Germany Historic Review for ePRO, E-Patient Diaries and eCOA by End-Use - Clinical Trial Sponsors, Contract Research Organizations (CROs), Hospitals, Academic Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 and % CAGR
  • Table 69: Germany 15-Year Perspective for ePRO, E-Patient Diaries and eCOA by End-Use - Percentage Breakdown of Value Sales for Clinical Trial Sponsors, Contract Research Organizations (CROs), Hospitals, Academic Institutes and Other End-Uses for the Years 2012, 2018 & 2027
  • ITALY
  • Table 70: Italy Current & Future Analysis for ePRO, E-Patient Diaries and eCOA by Type of Solution - eCOA and E-Patient Diaries - Independent Analysis of Annual Sales in US$ Thousand for the Years 2018 through 2027 and % CAGR
  • Table 71: Italy Historic Review for ePRO, E-Patient Diaries and eCOA by Type of Solution - eCOA and E-Patient Diaries Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 and % CAGR
  • Table 72: Italy 15-Year Perspective for ePRO, E-Patient Diaries and eCOA by Type of Solution - Percentage Breakdown of Value Sales for eCOA and E-Patient Diaries for the Years 2012, 2018 & 2027
  • Table 73: Italy Current & Future Analysis for ePRO, E-Patient Diaries and eCOA by End-Use - Clinical Trial Sponsors, Contract Research Organizations (CROs), Hospitals, Academic Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2018 through 2027 and % CAGR
  • Table 74: Italy Historic Review for ePRO, E-Patient Diaries and eCOA by End-Use - Clinical Trial Sponsors, Contract Research Organizations (CROs), Hospitals, Academic Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 and % CAGR
  • Table 75: Italy 15-Year Perspective for ePRO, E-Patient Diaries and eCOA by End-Use - Percentage Breakdown of Value Sales for Clinical Trial Sponsors, Contract Research Organizations (CROs), Hospitals, Academic Institutes and Other End-Uses for the Years 2012, 2018 & 2027
  • UNITED KINGDOM
  • Table 76: UK Current & Future Analysis for ePRO, E-Patient Diaries and eCOA by Type of Solution - eCOA and E-Patient Diaries - Independent Analysis of Annual Sales in US$ Thousand for the Years 2018 through 2027 and % CAGR
  • Table 77: UK Historic Review for ePRO, E-Patient Diaries and eCOA by Type of Solution - eCOA and E-Patient Diaries Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 and % CAGR
  • Table 78: UK 15-Year Perspective for ePRO, E-Patient Diaries and eCOA by Type of Solution - Percentage Breakdown of Value Sales for eCOA and E-Patient Diaries for the Years 2012, 2018 & 2027
  • Table 79: UK Current & Future Analysis for ePRO, E-Patient Diaries and eCOA by End-Use - Clinical Trial Sponsors, Contract Research Organizations (CROs), Hospitals, Academic Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2018 through 2027 and % CAGR
  • Table 80: UK Historic Review for ePRO, E-Patient Diaries and eCOA by End-Use - Clinical Trial Sponsors, Contract Research Organizations (CROs), Hospitals, Academic Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 and % CAGR
  • Table 81: UK 15-Year Perspective for ePRO, E-Patient Diaries and eCOA by End-Use - Percentage Breakdown of Value Sales for Clinical Trial Sponsors, Contract Research Organizations (CROs), Hospitals, Academic Institutes and Other End-Uses for the Years 2012, 2018 & 2027
  • REST OF EUROPE
  • Table 82: Rest of Europe Current & Future Analysis for ePRO, E-Patient Diaries and eCOA by Type of Solution - eCOA and E-Patient Diaries - Independent Analysis of Annual Sales in US$ Thousand for the Years 2018 through 2027 and % CAGR
  • Table 83: Rest of Europe Historic Review for ePRO, E-Patient Diaries and eCOA by Type of Solution - eCOA and E-Patient Diaries Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 and % CAGR
  • Table 84: Rest of Europe 15-Year Perspective for ePRO, E-Patient Diaries and eCOA by Type of Solution - Percentage Breakdown of Value Sales for eCOA and E-Patient Diaries for the Years 2012, 2018 & 2027
  • Table 85: Rest of Europe Current & Future Analysis for ePRO, E-Patient Diaries and eCOA by End-Use - Clinical Trial Sponsors, Contract Research Organizations (CROs), Hospitals, Academic Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2018 through 2027 and % CAGR
  • Table 86: Rest of Europe Historic Review for ePRO, E-Patient Diaries and eCOA by End-Use - Clinical Trial Sponsors, Contract Research Organizations (CROs), Hospitals, Academic Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 and % CAGR
  • Table 87: Rest of Europe 15-Year Perspective for ePRO, E-Patient Diaries and eCOA by End-Use - Percentage Breakdown of Value Sales for Clinical Trial Sponsors, Contract Research Organizations (CROs), Hospitals, Academic Institutes and Other End-Uses for the Years 2012, 2018 & 2027
  • ASIA-PACIFIC
  • Table 88: Asia-Pacific Current & Future Analysis for ePRO, E-Patient Diaries and eCOA by Type of Solution - eCOA and E-Patient Diaries - Independent Analysis of Annual Sales in US$ Thousand for the Years 2018 through 2027 and % CAGR
  • Table 89: Asia-Pacific Historic Review for ePRO, E-Patient Diaries and eCOA by Type of Solution - eCOA and E-Patient Diaries Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 and % CAGR
  • Table 90: Asia-Pacific 15-Year Perspective for ePRO, E-Patient Diaries and eCOA by Type of Solution - Percentage Breakdown of Value Sales for eCOA and E-Patient Diaries for the Years 2012, 2018 & 2027
  • Table 91: Asia-Pacific Current & Future Analysis for ePRO, E-Patient Diaries and eCOA by End-Use - Clinical Trial Sponsors, Contract Research Organizations (CROs), Hospitals, Academic Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2018 through 2027 and % CAGR
  • Table 92: Asia-Pacific Historic Review for ePRO, E-Patient Diaries and eCOA by End-Use - Clinical Trial Sponsors, Contract Research Organizations (CROs), Hospitals, Academic Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 and % CAGR
  • Table 93: Asia-Pacific 15-Year Perspective for ePRO, E-Patient Diaries and eCOA by End-Use - Percentage Breakdown of Value Sales for Clinical Trial Sponsors, Contract Research Organizations (CROs), Hospitals, Academic Institutes and Other End-Uses for the Years 2012, 2018 & 2027
  • REST OF WORLD
  • Table 94: Rest of World Current & Future Analysis for ePRO, E-Patient Diaries and eCOA by Type of Solution - eCOA and E-Patient Diaries - Independent Analysis of Annual Sales in US$ Thousand for the Years 2018 through 2027 and % CAGR
  • Table 95: Rest of World Historic Review for ePRO, E-Patient Diaries and eCOA by Type of Solution - eCOA and E-Patient Diaries Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 and % CAGR
  • Table 96: Rest of World 15-Year Perspective for ePRO, E-Patient Diaries and eCOA by Type of Solution - Percentage Breakdown of Value Sales for eCOA and E-Patient Diaries for the Years 2012, 2018 & 2027
  • Table 97: Rest of World Current & Future Analysis for ePRO, E-Patient Diaries and eCOA by End-Use - Clinical Trial Sponsors, Contract Research Organizations (CROs), Hospitals, Academic Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2018 through 2027 and % CAGR
  • Table 98: Rest of World Historic Review for ePRO, E-Patient Diaries and eCOA by End-Use - Clinical Trial Sponsors, Contract Research Organizations (CROs), Hospitals, Academic Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 and % CAGR
  • Table 99: Rest of World 15-Year Perspective for ePRO, E-Patient Diaries and eCOA by End-Use - Percentage Breakdown of Value Sales for Clinical Trial Sponsors, Contract Research Organizations (CROs), Hospitals, Academic Institutes and Other End-Uses for the Years 2012, 2018 & 2027
IV. COMPETITION
  • Total Companies Profiled: 46
Note: Product cover images may vary from those shown

A selection of companies mentioned in this report includes:

  • ArisGlobal LLC
  • Bracket Global LLC
  • CRF Health
  • ERT Clinical
  • HealthDiary Inc.
  • ICON PLC
  • Kayentis SAS
  • Medidata Solutions, Inc.
  • OmniComm Systems, Inc.
  • Parexel International Corporation
Note: Product cover images may vary from those shown
Adroll
adroll